The store will not work correctly when cookies are disabled.
(Z)-5-(4-bromobenzylidene)-3-((phenylsulfonyl)methyl)-2-thioxothiazolidin-4-one
ID: ALA5272023
Max Phase: Preclinical
Molecular Formula: C17H12BrNO3S3
Molecular Weight: 454.39
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1/C(=C/c2ccc(Br)cc2)SC(=S)N1CS(=O)(=O)c1ccccc1
Standard InChI: InChI=1S/C17H12BrNO3S3/c18-13-8-6-12(7-9-13)10-15-16(20)19(17(23)24-15)11-25(21,22)14-4-2-1-3-5-14/h1-10H,11H2/b15-10-
Standard InChI Key: HQZSZCAEPUQWBO-GDNBJRDFSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
2.2224 -0.6916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8122 0.0242 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.3973 -0.6890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6746 -0.4654 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.1542 -0.4654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4122 0.3222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2601 0.8112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9283 0.3222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2613 1.6402 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6408 -1.1367 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2009 0.5772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7167 0.5780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3326 0.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1202 0.2813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7356 -0.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5631 -1.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7698 -1.3390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1577 -0.7831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1783 -1.6402 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2.6050 0.2768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2161 -0.2807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0042 -0.0262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1783 0.7850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5580 1.3415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7724 1.0840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
7 9 2 0
5 10 2 0
6 11 1 0
11 2 1 0
8 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
2 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 454.39 | Molecular Weight (Monoisotopic): 452.9163 | AlogP: 4.08 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.45 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.89 | CX Basic pKa: ┄ | CX LogP: 4.48 | CX LogD: 4.48 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.51 | Np Likeness Score: -1.76 |